| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 9e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |